Bridging Gaps, Optimizing Treatment in Adults with LC-FAODs

To participate in this activity, please:

Log in Sign Up

Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs. Triheptanoin is an odd-carbon MCT designed to bypass the metabolic block in LC-FAODs, recently approved as an alternative treatment option. The faculty discuss the safety and efficacy of triheptanoin and their real-world experience initiating and optimizing it to bridge critical care gaps in patients with LC-FAODs. They briefly orient learners to a downloadable, point-of-care resource for patient education developed as part of this accredited activity.

This content is also availble as a podcast: You may listen here.  In addition, you can access a companion activity focused on interprofessional collaboration here.

This activity is developed in collaboration with Genetic Metabolic Dietitians International (GMDI)

Course Credit:

0.75 AMA PRA Category 1 CreditsTM
0.75 ANCC Contact Hours
0.75 CA-BRN Contact Hours
0.75 CDR Contact Hours

Dates:

Opens: 2024-11-25
Closes: 2025-11-25

Target Audience:

This activity is intended for metabolic dieticians, nurse practitioners, nurses, and metabolic disease specialists working within Inborn Errors of Metabolism (IEM) clinics in the United States and Canada who care for patients with long chain fatty acid oxidation disorders (LC-FAODs).

This activity is supported by an educational grant from Ultragenyx Pharmaceutical Inc.

Accreditation Information

    Presenting Faculty

  • Sandra Carol van Calcar, PhD, RD, LD headshot

    Sandra Carol van Calcar, PhD, RD, LD

    Associate Professor of Molecular and Medical Genetics
    School of Medicine
    Oregon Health and Science University
    Portland, Oregon

  • Jerry Vockley, MD, PhD headshot

    Jerry Vockley, MD, PhD

    University of Pittsburgh
    Cleveland Family Endowed Chair in Pediatric Research
    Professor of Human Genetics
    UPMC Children's Hospital of Pittsburgh
    Chief of Genetic and Genomic Medicine
    Director of the Center for Rare Disease Therapy
    Pittsburgh, Pennsylvania